XERS Xeris delivers 336 percent Q4 2025 EPS beat shares rise 168 percent in todays trading session Syndax Pharmaceuticals SNDX Stock Price Movement Behavior Q4 2025 Earnings Underperform Can Grupo Aval AVAL stock sustain longterm growth Grupo Aval posts 40205 EPS no analyst estimates